UNSPSC 51383400: Nonsteroidal anti inflammatory indoleacetic acids

Nonsteroidal anti inflammatory drugs made from acetic acid derivatives of the heterocyclic compound indole, hence the names INDOLEA-CETIC ACIDS or INDOLEACETIC ACIDS.

UNSPSC 51383400 Nonsteroidal anti inflammatory indoleacetic acids is a Class code, but recent state and local opportunities tagged under it show minimal alignment with the code's nominal pharmaceutical scope. The three opportunities on record — a Seminole County, Florida naloxone and drug deactivation systems procurement, a Texas Health and Human Services Commission Request for Information on direct-to-manufacturer prescription programs, and a Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) RFP for generic multi-source pharmaceuticals and OTC products — span pharmaceutical supply, pharmacy benefit management, and emergency-response drugs rather than nonsteroidal anti-inflammatory indoleacetic acids specifically. State and local buyers under this code include county health departments, state HHS commissions, and multistate cooperative purchasing alliances. The actual work being procured includes naloxone supply contracts for harm-reduction initiatives, market exploration of direct-to-manufacturer pharmacy channels, and generic pharmaceutical supply agreements through authorized wholesalers.

Geographic activity centers on Florida, Texas, and Minnesota, with the MMCAP cooperative also serving Oregon and other participating jurisdictions. The representative recent opportunities are Seminole County's IFB60459723LAS (posted June 30, 2026, response due July 26, 2023) for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to Sanford, Florida; the Texas HHS Commission's RFI HHS0017013 (posted April 3, 2026) exploring vendor capabilities for direct prescription contracting outside traditional PBM and wholesaler channels; and MMCAP's S1070000015802 RFP (posted January 20, 2026, responses due March 26, 2026) establishing multiple-award contracts for generic pharmaceuticals and OTC products through AmerisourceBergen, Cardinal Health, and Morris & Dickson, with awarded vendors effective July 1, 2026. The code shows limited recent activity explicitly tagged to nonsteroidal anti-inflammatory indoleacetic acids; misalignment between the code designation and the work actually being solicited suggests this code may not reflect how state and local procurement offices are currently categorizing pharmaceutical purchases.